Cost-utility of COBRA-light versus COBRA therapy in patients with early rheumatoid arthritis: the COBRA-light trial

ObjectiveTo evaluate if COmbinatie therapie Bij Reumatoïde Artritis (COBRA)-light therapy is cost-effective in treating patients with early rheumatoid arthritis (RA) compared with COBRA therapy.MethodsThis economic evaluation was performed next to the open-label, randomised non-inferiority COBRA-lig...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Rheumatic & musculoskeletal diseases open 2017-10, Vol.3 (2), p.e000502-e000502
Hauptverfasser:	ter Wee, Marieke M, Coupé, Veerle MH, den Uyl, Debby, Blomjous, Birgit S, Kooijmans, Esmee, Kerstens, Pit JSM, Nurmohamed, Mike T, van Schaardenburg, Dirkjan, Voskuyl, Alexandre E, Boers, Maarten, Lems, Willem F
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical medicine Cost analysis Diaries Drug dosages Light Patients Pharmacoeconomics Quality of life Rheumatoid Arthritis Studies Tumor necrosis factor-TNF
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!